Atlas Trials

Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study)

Clinical trial NCT04091386 · COMPLETED

Trial details

NCT number
NCT04091386
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Hemophilia A
Start date
2021-06-10
Primary completion
2024-05-07
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.